DOCSLIB.ORG

Differential Binding of Marvcf to Cadherins 3875

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Differential Binding of Marvcf to Cadherins 3875 RESEARCH ARTICLE 3873 mARVCF cellular localisation and binding to cadherins is influenced by the cellular context but not by alternative splicing Zoe Waibler, Annette Schäfer and Anna Starzinski-Powitz* Institut der Anthropologie und Humangenetik fuer Biologen, Johann-Wolfgang-Goethe-Universitaet Frankfurt, Siesmayerstrasse 70, D-60054 Frankfurt/Main, Germany *Author for correspondence (e-mail: [email protected]) Accepted 23 July 2001 Journal of Cell Science 114, 3873-3884 (2001) © The Company of Biologists Ltd SUMMARY ARVCF, a member of the catenin family, is thought to isoforms to M-, N-, or E-cadherin is generally unaffected contribute to the morphoregulatory function of the by their altered N- and C-termini, as revealed by the MOM cadherin-catenin complex. Recently, we reported the recruitment assay. However, mARVCF isoforms isolation and characterisation of murine ARVCF reproducibly exhibit differential localisation in distinct (mARVCF), particularly its interaction with M-cadherin. cellular environments. For example, mARVCF isoforms Here, we describe the identification of novel mARVCF are unable to colocalise with N-cadherin in EJ28 carcinoma isoforms that arise by alternative splicing. At the N- cells but do so in HeLa cells. Our results suggest that the terminus, alternative splicing results in the inclusion or subcellular localisation of mARVCF may be determined omission of a coiled-coil region probably important for not only by the presence or absence of an appropriate protein-protein interactions. At the C-terminus, four interaction partner, in this case cadherins, but also by the isoforms also differ by domains potentially important for cellular context. selective protein-protein interaction. The eight putative mARVCF isoforms were expressed as EGFP-fusion proteins in six different cell lines that exhibit a distinct Key words: p120(ctn) subfamily, MOM recruitment assay, Armadillo pattern of cadherins. Apparently, binding of the mARVCF repeat protein INTRODUCTION The human gene maps to chromosome 22q11, the so-called DiGeorge critical region (Sirotkin et al., 1997; Bonne et al., One of the most recently identified members of the p120(ctn) 1998), which is hemizygous in 80-85% of DiGeorge patients subfamily, the murine ARVCF protein (armadillo repeat gene and those with velo cardio facial syndrome (Desmaze et al., deleted in velo cardio facial syndrome) comprises an N- 1993; Kelly et al., 1993; Morrow et al., 1995). Human ARVCF terminal coiled-coil region and a central armadillo repeat appears to be more or less ubiquitously expressed, being found region. This structure closely resembles that of p120(ctn) itself in a variety of tissues including heart, skeletal muscle, lung, (Sirotkin et al., 1997; Kaufmann et al., 2000; Mariner et al., brain, liver, pancreas and kidney (Sirotkin et al., 1997). 2000; Anastasiadis and Reynolds, 2000). Not only do the Murine and human ARVCF can associate with the armadillo repeat regions of both proteins share 56% homology membrane proximal amino acids in the cytoplasmic region of but also exon-intron boundaries of the genes are very similar cadherins such as E-cadherin in epithelial cells and M-cadherin (Keirsebilck et al., 1998). The 35 amino acid N-terminal in muscle cells (Reynolds et al., 1994; Kaufmann et al., 2000; coiled-coil region of ARVCF (Sirotkin et al., 1997; Kaufmann Mariner et al., 2000). This was shown in detail by binding et al., 2000) is generally known as a motif mediating protein- assays using GST-fusion proteins comprising the cytoplasmic protein interactions, although such interactions have not yet domain of M-cadherin plus several deletion mutants, been demonstrated for ARVCF or any other member of this demonstrating that the 55 membrane-proximal CPD amino subfamily. ARVCF’s armadillo repeat region is characterised acids of M-cadherin are necessary and sufficient for ARVCF by 10 of these repeats and a putative nuclear localisation signal binding. Vice versa, all ten armadillo repeats of ARVCF are (NLS) within this region, in addition to a putative nuclear necessary for efficient M-cadherin binding. Deletion of repeats export signal (NES) in the C-terminus of the protein (Sirotkin 1 to 4 or 1 to 5 abolished the ability of ARVCF to colocalise et al., 1997; Kaufmann et al., 2000). The armadillo motif, with N-cadherin in rat ventricular cardiomyocytes, although originally identified in a segment polarity gene in drosophila such deletions still facilitated some interactions in vitro (Wieschaus and Rigglemann, 1987), consists of an imperfect (Kaufmann et al., 2000). However, whether ARVCF directly series of 42 amino acids that form a positively charged groove connects the cadherin complex to the cytoskeleton or is (Riggleman et al., 1989). involved in cadherin clustering is not yet clear. 3874 JOURNAL OF CELL SCIENCE 114 (21) In human ARVCF two alternative splicing events have been show that the appearance of the isoforms varies depending on reported. One concerns the N-terminus leading to the removal the cell line or tissue examined. Cloned as EGFP-fusion of the coiled-coil domain and the use of an alternative start proteins and expressed in different cell lines we demonstrate codon. The second splice event leads to the insertion of an 18 that the localisation of mARVCF isoforms is not influenced by base pair exon in the armadillo region that alters the putative the N- or C-terminus of the protein but depends on the cellular NLS (Sirotkin et al., 1997). It has also been shown for context. Using the MOM recruitment assay we examined the p120(ctn) and other members of the subfamily that different ability of all isoforms to associate with M-, E- or N-cadherin isoforms can arise by alternative splicing (Hatzfeld, 1999; in different cell types. Paulson et al., 2000). For p120(ctn) itself this applies to the N- terminus where alternative splicing leads to the use of different start codons. Furthermore, the armadillo repeat region and the MATERIALS AND METHODS C-terminus can be altered by using three alternative exons (Keirsebilck et al., 1998). Cells, cell culture, plasmid transfection Cadherins are a multigene family of calcium-dependent Mouse myoblasts, i28, derived from a primary satellite cell culture transmembrane cell-cell adhesion glycoproteins that mediate (Kaufmann et al., 1999b) were grown in Ham’s nutrient mixture F10 homophilic interactions and are expressed in a tissue-specific (Gibco) supplemented with 20% fetal calf serum (FCS; Sigma) in 5% CO2 at 37°C. To initiate myogenic differentiation, growth medium manner (Ringwald et al., 1987; Takeichi, 1991; Geiger and was replaced by differentiation medium consisting of Dulbecco’s Ayalon, 1992; Shapiro et al., 1995; Huber et al., 1996). Many modified Eagle’s (DMEM) medium (Gibco) with 10% horse serum of the cadherins have been classified according to the tissues (Sigma, Buchs, Switzerland). MCF7 cells, HeLa cells, CMT cells, from which they have been isolated, such as P-cadherin from EJ28 cells, COS-7 cells and RT112 cells were grown in DMEM placenta, E-cadherin first isolated from epithelial cells or M- supplemented with 10% FCS. The cells were transfected with 2 µg cadherin from muscle. The classical cadherins (and M- plasmid DNA using SuperFect Transfection Reagent, or with 1.5 cadherin) consist of an N-terminal extracellular domain, a short µg plasmid DNA using PolyFect Transfection Reagent, both from transmembrane region and a cytoplasmic domain (CPD) Qiagen (Hilden, Germany). For the MOM recruitment assay, cells were cotransfected with 1 µg pMOM-M/E/N-cadherin vector and 1 averaging 150-160 amino acids, which all exhibit a high degree µ of homology with each other (Chothia and Jones, 1997; g of either of the mARVCF EGFP-fusion plasmids (see plasmid constructions). The different cell types were subjected to Humphries and Newham, 1998; Kaufmann et al., 1999a). Most immunofluorescence microscopy 24-48 hours after transfection. Cells cadherins are known to form two distinct complexes with used in addition to i28 were: MCF7 human breast carcinoma cells catenins via their CPD (Ozawa et al., 1989; Hirano et al., 1992; (ATCC HTB-22); COS-7 kidney cells from African green monkey Aberle et al., 1994; Butz and Kemler, 1994; Hinck et al., 1994; (ATCC CRL-1651); HeLa human cervix carcinoma cells (ATCC Näthke et al., 1994; Knudsen et al., 1995; Hertig et al., 1996; CCL-2.1); RT112 human, non-invasive bladder carcinoma cells and Kuch et al., 1997; Finnemann et al., 1997; Yap et al., 1998; EJ28 human, invasive bladder carcinoma cells (Gaetje et al., 1997). Allport et al., 2000). One complex is composed of the respective cadherin, β-catenin and α-catenin, a second Antibodies complex contains cadherin, plakoglobin (also called γ-catenin) The monoclonal antibody 4A6 described previously (Rüdiger et al., and α-catenin. α-catenin joins the complex by binding to β- 1997) was used to identify the birch profilin (BP) tag. Monoclonal anti-GFP antibody was obtained from Clontech (Heidelberg, catenin or plakoglobin and connects this cadherin-catenin Germany). Polyclonal antibodies against the extracellular domain of complex to components of the cytoskeleton (Hirano et al., M-cadherin were affinity-purified as described (Rose et al., 1994; 1987; Tsukita et al., 1992). β-catenin interacts with the C- Kaufmann et al., 1999b). Monoclonal pan-cadherin (clone CH-19) terminal part of cadherin’s CPD, whereas ARVCF and and monoclonal N-cadherin antibody (anti-A-CAM, clone GC-4) p120(ctn), for example, bind to the juxtamembrane region of were obtained from Sigma (Buchs, Switzerland). E-cadherin antibody the cadherin’s cytoplasmic tail, as discussed above. ARVCF was obtained from Monosan (Germany). Secondary antibody (Alexa and p120(ctn) compete for the same binding site in the CPD Fluor 568) was obtained from Molecular Probes (Leiden, The of cadherins (Mariner et al., 2000) but the different functions Netherlands). of the two molecules are as yet unknown. Immunofluorescence Many proteins of the armadillo repeat family are known to Cells grown on coverslips were rinsed in PBS and fixed in 4% enter the nucleus, although the mechanism and functional β paraformaldehyde (PFA) in PBS at room temperature for 10 minutes.
Load more

Recommended publications
  • (COMT) Gene As a Candidate for Psychiatric Phenotypes
    Molecular Psychiatry (2006) 11, 446–458 & 2006 Nature Publishing Group All rights reserved 1359-4184/06 $30.00 www.nature.com/mp FEATURE REVIEW The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons N Craddock, MJ Owen and MC O’Donovan Department of Psychological Medicine, The Henry Wellcome Building for Biomedical Research in Wales, Cardiff University, School of Medicine, Heath Park, Cardiff, UK The enzyme catechol-O-methyl transferase (COMT), identified in the 1950s, is involved in catabolism of monoamines that are influenced by psychotropic medications, including neuroleptics and antidepressants. The COMT gene lies in a chromosomal region of interest for psychosis and bipolar spectrum disorder and a common polymorphism within the gene alters the activity of the enzyme. As a consequence, COMT has been one of the most studied genes for psychosis. On the basis of prior probabilities it would seem surprising if functional variation at COMT did not have some influence either on susceptibility to psychiatric phenotypes, modification of the course of illness or moderation of response to treatment. There is now robust evidence that variation at COMT influences frontal lobe function. However, despite considerable research effort, it has not proved straightforward to demonstrate and characterise a clear relationship between genetic variation at COMT and psychiatric phenotypes. It is of course, possible that COMT will turn out to be an unusually intractable case but it seems more likely that the experiences with this gene will provide a foretaste of the complexity of genotype–phenotype relationships that will be found for psychiatric traits.
    [Show full text]
  • The N-Cadherin Interactome in Primary Cardiomyocytes As Defined Using Quantitative Proximity Proteomics Yang Li1,*, Chelsea D
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs221606. doi:10.1242/jcs.221606 TOOLS AND RESOURCES The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics Yang Li1,*, Chelsea D. Merkel1,*, Xuemei Zeng2, Jonathon A. Heier1, Pamela S. Cantrell2, Mai Sun2, Donna B. Stolz1, Simon C. Watkins1, Nathan A. Yates1,2,3 and Adam V. Kwiatkowski1,‡ ABSTRACT requires multiple adhesion, cytoskeletal and signaling proteins, The junctional complexes that couple cardiomyocytes must transmit and mutations in these proteins can cause cardiomyopathies (Ehler, the mechanical forces of contraction while maintaining adhesive 2018). However, the molecular composition of ICD junctional homeostasis. The adherens junction (AJ) connects the actomyosin complexes remains poorly defined. – networks of neighboring cardiomyocytes and is required for proper The core of the AJ is the cadherin catenin complex (Halbleib and heart function. Yet little is known about the molecular composition of the Nelson, 2006; Ratheesh and Yap, 2012). Classical cadherins are cardiomyocyte AJ or how it is organized to function under mechanical single-pass transmembrane proteins with an extracellular domain that load. Here, we define the architecture, dynamics and proteome of mediates calcium-dependent homotypic interactions. The adhesive the cardiomyocyte AJ. Mouse neonatal cardiomyocytes assemble properties of classical cadherins are driven by the recruitment of stable AJs along intercellular contacts with organizational and cytosolic catenin proteins to the cadherin tail, with p120-catenin β structural hallmarks similar to mature contacts. We combine (CTNND1) binding to the juxta-membrane domain and -catenin β quantitative mass spectrometry with proximity labeling to identify the (CTNNB1) binding to the distal part of the tail.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions
    Supp. Table S2: Domains and protein families with a putative role in host-symbiont interactions. The domains and protein families listed here were included in the comparisons in Figure 5 and Supp. Figure S5, which show the percentage of the respective protein groups in the Riftia symbiont metagenome and in metagenomes of other symbiotic and free-living organisms. % bacterial, total number bacterial: Percentage and total number of bacterial species in which this domain is found in the SMART database (January 2019). Domain name Pfam/SMART % bacterial (total Literature/comment annotation number bacterial) Alpha-2- alpha-2- A2M: 42.05% (2057) A2Ms: protease inhibitors which are important for eukaryotic macroglobulin macroglobulin innate immunity, if present in prokaryotes apparently fulfill a family (A2M), similar role, e.g. protection against host proteases (1) including N- terminal MG1 domain ANAPC Anaphase- APC2: 0 Ubiquitin ligase, important for cell cycle control in eukaryotes (2) promoting complex Bacterial proteins might interact with ubiquitination pathways in subunits the host (3) Ankyrin Ankyrin repeats 10.88% (8348) Mediate protein-protein interactions without sequence specificity (4) Sponge symbiont ankyrin-repeat proteins inhibit amoebal phagocytosis (5) Present in sponge microbiome metatranscriptomes, putative role in symbiont-host interactions (6) Present in obligate intracellular amoeba symbiont Candidatus Amoebophilus asiaticus genome, probable function in interactions with the host (7) Armadillo Armadillo repeats 0.83% (67)
    [Show full text]
  • 'Histology and Immunophenotype of Invasive Lobular Breast Cancer
    Varga, Z; Mallon, E (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Breast Disease, 30:15-19. Postprint available at: http://www.zora.uzh.ch University of Zurich Posted at the Zurich Open Repository and Archive, University of Zurich. Zurich Open Repository and Archive http://www.zora.uzh.ch Originally published at: Breast Disease 2009, 30:15-19. Winterthurerstr. 190 CH-8057 Zurich http://www.zora.uzh.ch Year: 2009 Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls Varga, Z; Mallon, E Varga, Z; Mallon, E (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Breast Disease, 30:15-19. Postprint available at: http://www.zora.uzh.ch Posted at the Zurich Open Repository and Archive, University of Zurich. http://www.zora.uzh.ch Originally published at: Breast Disease 2009, 30:15-19. Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls Abstract Invasive lobular carcinomas (ILC) represent the most common subtype of invasive breast cancer and account for about 5-15% of all breast cancer cases. Invasive lobular carcinoma is often accompanied by in situ lesions, by lobular neoplasia (LN). Invasive lobular carcinomas display diverse histologic patterns varying from classical through solid to pleomorphic subtypes. When analyzing histological subtypes, the classical variant is reported to have a more favorable outcome. The majority of invasive lobular carcinomas are hormone receptor positive, overexpression and/or amplification of the Her2 gene is lower than in carcinomas of invasive ductal type. Loss of heterozygosity of the 16q chromosomal regions and the consequent lack of E-Cadherin expression are common findings in invasive lobular carcinomas.
    [Show full text]
  • CDH1 Gene Cadherin 1
    CDH1 gene cadherin 1 Normal Function The CDH1 gene provides instructions for making a protein called epithelial cadherin or E-cadherin. This protein is found within the membrane that surrounds epithelial cells, which are the cells that line the surfaces and cavities of the body, such as the inside of the eyelids and mouth. E-cadherin belongs to a family of proteins called cadherins whose function is to help neighboring cells stick to one another (cell adhesion) to form organized tissues. Another protein called p120-catenin, produced from the CTNND1 gene, helps keep E-cadherin in its proper place in the cell membrane, preventing it from being taken into the cell through a process called endocytosis and broken down prematurely. E-cadherin is one of the best-understood cadherin proteins. In addition to its role in cell adhesion, E-cadherin is involved in transmitting chemical signals within cells, controlling cell maturation and movement, and regulating the activity of certain genes. Interactions between the E-cadherin and p120-catenin proteins, in particular, are thought to be important for normal development of the head and face (craniofacial development), including the eyelids and teeth. E-cadherin also acts as a tumor suppressor protein, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. Health Conditions Related to Genetic Changes Breast cancer Inherited mutations in the CDH1 gene increase a woman's risk of developing a form of breast cancer that begins in the milk-producing glands (lobular breast cancer). In many cases, this increased risk occurs as part of an inherited cancer disorder called hereditary diffuse gastric cancer (HDGC) (described below).
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Studies of Epigenetic Deregulation in Parathyroid Tumors and Small Intestinal Neuroendocrine Tumors
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1377 Studies of epigenetic deregulation in parathyroid tumors and small intestinal neuroendocrine tumors ELHAM BARAZEGHI ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-513-0097-9 UPPSALA urn:nbn:se:uu:diva-330810 2017 Dissertation presented at Uppsala University to be publicly examined in Fåhraeussalen, Rudbecklaboratoriet Hus 5, Dag Hammarskjölds väg 20, Uppsala, Friday, 24 November 2017 at 13:15 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: Associate Professor Christofer Juhlin (Department of Oncology-Pathology, Karolinska Institute). Abstract Barazeghi, E. 2017. Studies of epigenetic deregulation in parathyroid tumors and small intestinal neuroendocrine tumors. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1377. 53 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0097-9. Deregulation of the epigenome is associated with the initiation and progression of various types of human cancers. Here we investigated the level of 5-hydroxymethylcytosine (5hmC), expression and function of TET1 and TET2, and DNA methylation in parathyroid tumors and small intestinal neuroendocrine tumors (SI-NETs). In Paper I, an undetectable/very low level of 5hmC in parathyroid carcinomas (PCs) compared to parathyroid adenomas with positive staining, suggested that 5hmC may represent a novel biomarker for parathyroid malignancy. Immunohistochemistry revealed that increased tumor weight in adenomas was associated with a more aberrant staining pattern of 5hmC and TET1. A growth regulatory role of TET1 was demonstrated in parathyroid tumor cells. Paper II revealed that the expression of TET2 was also deregulated in PCs, and promoter hypermethylation was detected in PCs when compared to normal parathyroid tissues.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Somatic Mutational Landscapes of Adherens Junctions and Their
    1 Somatic mutational landscapes of adherens junctions and their 2 functional consequences in cutaneous melanoma development 3 4 Praveen Kumar Korla,1 Chih-Chieh Chen,2 Daniel Esguerra Gracilla,1 Ming-Tsung Lai,3 Chih- 5 Mei Chen,4 Huan Yuan Chen,5 Tritium Hwang,1 Shih-Yin Chen,4,6,* Jim Jinn-Chyuan Sheu1,4, 6-9,* 6 1Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80242, Taiwan; 7 2Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, 8 Taiwan; 3Department of Pathology, Taichung Hospital, Ministry of Health and Welfare, Taichung 9 40343, Taiwan; 4Genetics Center, China Medical University Hospital, Taichung 40447, Taiwan; 10 5Institute of Biomedical Sciences, Academia Sinica, Taipei 11574, Taiwan; 6School of Chinese 11 Medicine, China Medical University, Taichung 40402, Taiwan; 7Department of Health and 12 Nutrition Biotechnology, Asia University, Taichung 41354, Taiwan; 8Department of 13 Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; 9Institute of 14 Biopharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung 80242, Taiwan 15 16 PKK, CCC and DEG contributed equally to this study. 17 *Correspondence to: Dr. Shih-Yin Chen ([email protected]) at Genetics Center, China 18 Medical University Hospital, Taichung, 40447, TAIWAN; or Dr. Jim Jinn-Chyuan Sheu 19 ([email protected]) at Institute of Biomedical Sciences, National Sun Yat-sen 20 University, Kaohsiung City 80424, TAIWAN. 21 22 Running title: mutational landscape of cadherins in melanoma 1 23 Abstract 24 Cell-cell interaction in skin homeostasis is tightly controlled by adherens junctions (AJs). 25 Alterations in such regulation lead to melanoma development.
    [Show full text]
  • Armc5 Deletion Causes Developmental Defects and Compromises T-Cell Immune Responses
    ARTICLE Received 26 Jan 2016 | Accepted 4 Nov 2016 | Published 7 Feb 2017 DOI: 10.1038/ncomms13834 OPEN Armc5 deletion causes developmental defects and compromises T-cell immune responses Yan Hu 1,*, Linjiang Lao1,*, Jianning Mao1, Wei Jin1, Hongyu Luo1, Tania Charpentier2, Shijie Qi1, Junzheng Peng1, Bing Hu3, Mieczyslaw Martin Marcinkiewicz4, Alain Lamarre2 & Jiangping Wu1,5 Armadillo repeat containing 5 (ARMC5) is a cytosolic protein with no enzymatic activities. Little is known about its function and mechanisms of action, except that gene mutations are associated with risks of primary macronodular adrenal gland hyperplasia. Here we map Armc5 expression by in situ hybridization, and generate Armc5 knockout mice, which are small in body size. Armc5 knockout mice have compromised T-cell proliferation and differentiation into Th1 and Th17 cells, increased T-cell apoptosis, reduced severity of experimental autoimmune encephalitis, and defective immune responses to lymphocytic choriomeningitis virus infection. These mice also develop adrenal gland hyperplasia in old age. Yeast 2-hybrid assays identify 16 ARMC5-binding partners. Together these data indicate that ARMC5 is crucial in fetal development, T-cell function and adrenal gland growth homeostasis, and that the functions of ARMC5 probably depend on interaction with multiple signalling pathways. 1 Centre de recherche (CR), Centre hospitalier de l’Universite´ de Montre´al (CHUM), 900 Rue Saint Denis, Montre´al, Que´bec, Canada H2X 0A9. 2 Institut national de la recherche scientifique—Institut Armand-Frappier (INRS-IAF), 531 Boul. des Prairies, Laval, Que´bec, Canada H7V 1B7. 3 Anatomic Pathology, AmeriPath Central Florida, 4225 Fowler Ave. Tampa, Orlando, Florida 33617, USA.
    [Show full text]
  • Discovery and Systematic Characterization of Risk Variants and Genes For
    medRxiv preprint doi: https://doi.org/10.1101/2021.05.24.21257377; this version posted June 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . 1 Discovery and systematic characterization of risk variants and genes for 2 coronary artery disease in over a million participants 3 4 Krishna G Aragam1,2,3,4*, Tao Jiang5*, Anuj Goel6,7*, Stavroula Kanoni8*, Brooke N Wolford9*, 5 Elle M Weeks4, Minxian Wang3,4, George Hindy10, Wei Zhou4,11,12,9, Christopher Grace6,7, 6 Carolina Roselli3, Nicholas A Marston13, Frederick K Kamanu13, Ida Surakka14, Loreto Muñoz 7 Venegas15,16, Paul Sherliker17, Satoshi Koyama18, Kazuyoshi Ishigaki19, Bjørn O Åsvold20,21,22, 8 Michael R Brown23, Ben Brumpton20,21, Paul S de Vries23, Olga Giannakopoulou8, Panagiota 9 Giardoglou24, Daniel F Gudbjartsson25,26, Ulrich Güldener27, Syed M. Ijlal Haider15, Anna 10 Helgadottir25, Maysson Ibrahim28, Adnan Kastrati27,29, Thorsten Kessler27,29, Ling Li27, Lijiang 11 Ma30,31, Thomas Meitinger32,33,29, Sören Mucha15, Matthias Munz15, Federico Murgia28, Jonas B 12 Nielsen34,20, Markus M Nöthen35, Shichao Pang27, Tobias Reinberger15, Gudmar Thorleifsson25, 13 Moritz von Scheidt27,29, Jacob K Ulirsch4,11,36, EPIC-CVD Consortium, Biobank Japan, David O 14 Arnar25,37,38, Deepak S Atri39,3, Noël P Burtt4, Maria C Costanzo4, Jason Flannick40, Rajat M 15 Gupta39,3,4, Kaoru Ito18, Dong-Keun Jang4,
    [Show full text]